James P. Ohr

5.7k citations
55 papers · 4.1k · 1 hit paper · h-index 25

Impact in

    • Head and Neck Cancer Studies
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • CAR-T cell therapy research

Papers in

    • Head and Neck Cancer Studies 37
    • Cancer Immunotherapy and Biomarkers 8
    • Cancer Diagnosis and Treatment 3
    • Lung Cancer Research Studies 2

James P. Ohr

53 papers receiving 4.0k citations

James P. Ohr's Hit Papers

Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study 2019 · 2.5k citations
2.5k0+2+4Years since publication50010001.5k2.0k

Peers

James P. Ohr
Comparison fields: 5 of 97
  • Otorhinolaryngology 1.5k
  • Oncology 1.8k
  • Immunology 556
  • Cancer Research 346
  • Pulmonary and Respiratory Medicine 684
Replace Milan Vošmik with:
Milan Vošmik Czechia
Åse Bratland Norway
Iris Gluck Israel
Orit Gutfeld Israel
Simon A. Laban Germany
Niels Gyldenkerne Denmark
Johnny Kao United States
Yungan Tao France
Meltem Ekenel Türkiye
Lionnel Geoffrois France
James P. Ohr relative to Milan Vošmik Czechia Milan Vošmik's profile →
Citations per field
00.5×1.5×2.1×
Milan Vošmik · 1×
Citations per year

Countries citing papers authored by James P. Ohr

Since Specialization
Citations

This map shows the geographic impact of James P. Ohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. Ohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. Ohr more than expected).

Fields of papers citing papers by James P. Ohr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. Ohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. Ohr. The network helps show where James P. Ohr may publish in the future.

Co-authors

The 25 scholars most cited alongside James P. Ohr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James P. Ohr Line = papers co-authored together James P. Ohr links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Hit paper breakdown →
20192460
2 2019137
3 2015120
4 2018113
5 201989
6 201875
7 201773
8 202073
9 202070
10 201354
11 201653
12 202250
13 201247
14 201346
15 201139
16 201439
17 201639
18 201336
19 201732
20 202229

About James P. Ohr

James P. Ohr is a scholar working on Otorhinolaryngology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Radiation, having authored 55 papers that have together received 4.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (37 papers), Cancer Immunotherapy and Biomarkers (8 papers), Brain Metastases and Treatment (4 papers), Head and Neck Surgical Oncology (4 papers), Cancer Diagnosis and Treatment (3 papers), Lung Cancer Treatments and Mutations (3 papers), Lung Cancer Research Studies (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Otorhinolaryngology (1.5k citations), Oncology (1.8k citations), Immunology (556 citations), Cancer Research (346 citations) and Pulmonary and Respiratory Medicine (684 citations). James P. Ohr has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Robert Louis Ferris, Dwight Earl Heron, Jonas Talmadge Johnson, Julie E. Bauman, Umamaheswar Duvvuri, David Andrew Clump, Seungwon Kim, Barton F. Branstetter, John Austin Vargo and William E. Gooding. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Head & Neck, Annals of Oncology, Clinical Cancer Research and Oral Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact